Autumn 1999 – MAPS Israel MDMA Conference

MAPS organized an international symposium on the medical utility of MDMA. Talks from this event, held August 31 to September 1, 1999, are posted on this site (talks by George Greer, Juraj and Sonja Styk …

MDMA Teleconference

Teleconference with the FDA concerning MDMA psychotherapy research to treat anxiety, depression and pain in cancer patients, the FDA indicates a willingness to approve a “proof of principle” …

Level of Use of 3,4-methylenedioxymethamphetamine (MDMA)

Investigators: Dafters RI, Duffy F, O’Donnell P, Bouquet C Psychology Department, Glasgow University, Glasgow, Scotland G12 8RT Sponsor(s)/Funding: Self funded Contact: N/A References: Psychopharmacology …

FY 1999 Financial Report

MAPS IRS Form 990 for 1999 in PDF format Fiscal Year June 1, 1998 – May 31, 1999 (FY 98-99) was another year of significant accomplishments. More than twice as much money was devoted to educational …

Follow-up Study of Janiger LSD Research

Investigators: Rick Doblin, Jerry Beck, PhD, Kate Chapman, Maureen Alioto Los Angeles Area, California Contact Sponsor: MAPS The following report constitutes a forty-year+ follow-up interview study of …

MDMA and Memory

Investigators: Karen Bolla, PhD et al. Johns Hopkins University – Baltimore, Maryland Sponsor: NIH Neuropsychological memory testing of MDMA users and controls. Also see Alex Gamma – MDMA and …

MDMA Pharmacokinetics

Investigator: Rudolf Brenneisen, PhD University of Bern, Switzerland Contact: br> Completed and published, just a few subjects. Also see the details and references section.

MDMA Neurotoxicity Study

Investigators: Una McCann, MD, George Ricaurte, MD, PhD Johns Hopkins University – Baltimore, Maryland Sponsor:NIH PET scan study, MDMA Neurotoxicity, MDMA Users vs. Control Group. MAPS Commentary …